A randomized, pilot trial comparing vaginal hyaluronic acid to vaginal estrogen for the treatment of genitourinary syndrome of menopause.
Surbhi AgrawalZoe LaPierShavy NagpalAntoinette OotSteven FriedmanErinn M HadeLila NachtigallBenjamin M BruckerChristina EscobarPublished in: Menopause (New York, N.Y.) (2024)
There were no clinically meaningful differences between vaginal HLA and vaginal estrogen for the treatment of GSM after 12 wk. Vaginal HLA may be a promising non-hormone therapy for GSM.
Keyphrases